Abstract:Background: Catheter ablation of premature ventricular contractions (PVCs) that trigger polymorphic ventricular tachycardia (PVT) or ventricular fibrillation has been reported as a novel therapy to reduce the syncope events in patients with catecholaminergic PVT, whereas the long-term ablation outcome and its value in improving exercise-induced ventricular arrhythmias remain unclear. Methods and results: Fourteen consecutive selected patients with catecholaminergic PVT (mean±SD age, 16±6 years; 43% male patients) treated with maximum β-blockers with no possibility of adding flecainide were prospectively enrolled for catheter ablation. The primary end point was syncope recurrence, and the secondary end point was the reduction of the ventricular arrhythmia score during exercise testing. Twenty-six PVT/ventricular fibrillation-triggering PVCs were identified for ablation. The trigger beats arose from the left ventricle in 50% of the cases and from both ventricles in 36% of the cases. Purkinje potentials were observed at 27% of the targets. After a mean follow-up of 49 months after ablation, 8 (57%) patients were free from syncope recurrence. Ablation of trigger beat significantly reduced the syncope frequency (mean±SD, 4.3±1.6 to 0.5±0.8 events per year; P<0.001) and improved the ventricular arrhythmia scores at the 3-month (5 [range, 3-6] to 1.5 [range, 0-5]; P=0.002) and 12-month (5 [range, 3-6] to 2 [range, 0-5]; P=0.014) follow-ups. The induction of nontriggering PVCs postablation was closely associated with syncope recurrence (hazard ratio, 6.8 [95% CI, 1.3-35.5]; P=0.026). Conclusions: Catheter ablation of PVT/ventricular fibrillation-triggering PVCs in patients with catecholaminergic PVT who cannot receive flecainide treatment seems to be a safe and feasible adjunctive treatment that may reduce the syncope burden and improve exercise-related ventricular arrhythmias. Induction of nontriggering PVCs after ablation is associated with a higher risk of syncope recurrence.

The effect of the prevention pacing therapies to reduce the paroxysmal atrial fibrillation

The Prophylactic Effect of Special Pacing Therapy on Paroxysmal Atrial Fibrillation

Effect of Atrial Pacing Therapy with Selective Pacing Algorithms on Paroxysmal Atrial Fibrillation.

Inducibility and ablation of atrial fibrillation from non-pulmonary vein foci in patients with paroxysmal atrial fibrillation

Clinical evaluation of pacemaker automatic capture management and atrioventricular interval extension algorithm.

The Effect on Electrocardiographic and Cardiac Autonomic Function after Percutaneous Transluminal Septal Myocardial Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy

Antitachycardia pacing for primary and secondary prevention of sudden cardiac death in patients with an ICD implanted

Effect Comparison of Cardiac Dual-and Tri-chamber Pacmakers in the Prevention of Paroxysmal Atrial Tachyarrhythmias in Aging

"Preventive" pacing in patients with tachy-brady syndrome (TBS): Confirming a common practice

Characteristics of successful termination of atrial fibrillation by atrial antitachycardia pacing in patients with cardiac implantable electronic devices

Effect of atrial pacing proportion on atrial high-rate episodes after implantation of DDD pacemaker

Reduction of Unnecessary Right Ventricular Pacing by Managed Ventricular Pacing and Search AV+ Algorithms in Pacemaker Patients: 12-Month Follow-Up Results of a Randomized Study.

Study on the Effects of Atrial Electrophysiologic Properties and the Mechanism in Treatment of Atrial Fibrillation with Atrial Pacing

Prevention of the Initiation of Atrial Fibrillation: Mechanism and Efficacy of Different Atrial Pacing Modes

Atrial Pacing Improves Mitochondrial Function in Peripheral Blood Mononuclear Cells in Patients with Cardiac Implantable Electronic Devices

The Clinical Observation of Auto AV Search Algorithm in Dual Chamber Pacemaker.

Efficacy of Ablation Index-Guided Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation.

Effect of heart pacemaker on preventing and terminating chronic arrhythmia and its influence on cardiac function

Mapping and Ablation of Isolated Frequent Symptomatic Premature Atrial Contractions in Patients With Structurally Normal Heart

Interatrial Septal Pacing to Suppress Atrial Fibrillation in Patients with Dual Chamber Pacemakers: A Meta-Analysis of Randomized, Controlled Trials

Electrophysiological Characteristics and Ablation Outcomes in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia